Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection
The recent discovery of small molecules targeting the cytochrome bc 1 : aa 3 in Mycobacterium tuberculosis triggered interest in the terminal respiratory oxidases for antituberculosis drug development. The mycobacterial cytochrome bc 1 : aa 3 consists of a menaquinone:cytochrome c reductase ( bc 1 )...
Váldodahkkit: | , , , , , , , , , , , |
---|---|
Eará dahkkit: | |
Materiálatiipa: | Journal Article |
Giella: | English |
Almmustuhtton: |
2017
|
Fáttát: | |
Liŋkkat: | https://hdl.handle.net/10356/84353 http://hdl.handle.net/10220/43577 |